Cargando…
Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma
BACKGROUND: Anaplastic astrocytoma (AA; WHO grade-III) patients determination of prognostic factors helps generating multimodal therapy protocols. For this purpose, in the Baskent University, Adana Medical Research Center, specific characteristics of AA patients who have surgery were retrospectively...
Autores principales: | Sarica, Feyzi Birol, Cekinmez, Melih, Tufan, Kadir, Sen, Orhan, Onal, Huseyin C., Mertsoylu, Huseyin, Topkan, Erkan, Pehlivan, Berrin, Erdogan, Bulent, Altinors, Mehmet N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613640/ https://www.ncbi.nlm.nih.gov/pubmed/23559985 http://dx.doi.org/10.4103/1793-5482.106650 |
Ejemplares similares
-
Delayed radiation myelopathy: Differential diagnosis with positron emission tomography/computed tomography examination
por: Kadir, Tufan, et al.
Publicado: (2012) -
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013) -
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
por: Khaddour, Karam, et al.
Publicado: (2020) -
The genetic landscape of anaplastic astrocytoma
por: Killela, Patrick J., et al.
Publicado: (2013) -
Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide
por: Topkan, Erkan, et al.
Publicado: (2020)